Retinoblastoma
Primary Site | Histology | Staging Type |
---|---|---|
C690-C691, C693-C696, C698-C699 | 9510-9514 | Summary Stage only |
C692 | 9510-9514 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C690 Conjunctiva C691 Cornea, NOS C692 Retina C693 Choroid C694 Ciliary Body C695 Lacrimal Gland C696 Orbit, NOS C698 Overlapping lesion of eye and adnexa C699 Eye, NOS **Note 1:** This schema is based on the UICC chapter *Retinoblastoma,* pages 291-297. * Primary sites C690, C691, C693-C696, C698, and C699 are not listed in this chapter of the UICC manual; however, they are included in this schema * Only retinoblastomas with primary site C692 will be TNM staged * TNM is defined for this site; however, there is no stage group **Note 2:** Laterality must be coded for this site. In bilateral cases, the eyes should be classified separately. **Note 3:** This classification does not apply to complete spontaneous regression of the tumor. **Note 4:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Retinoblastoma* chapter on page 264 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=264).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 88 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 88 | Yes | NAACCR #910 | None | |
SSF2: Retinoblastoma (RB) Gene Mutation | 988 | No | NAACCR #2890 | None | None |
SSF3: Family History of Retinoblastoma | 988 | No | NAACCR #2900 | None | None |
SSF4: Primary Globe-Sparing Treatment Failure | 988 | No | NAACCR #2910 | None | None |
SSF5: Linear Choroidal Invasion | 988 | No | NAACCR #2920 | None | None |
SSF6: Clinical Extension for Second Eye | 988 | No | NAACCR #2930 | None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.1 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |